Press release
Non-Hodgkin Lymphoma Market - Pipeline Review, H1 2017 provides Comprehensive Information on the Therapeutics under Development
Non-Hodgkin Lymphoma - Pipeline Review, H1 2017
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H1 2017, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.
Non-Hodgkin lymphoma (also known as non-Hodgkin lymphoma, NHL, or sometimes just lymphoma) is a cancer that starts in cells called lymphocytes, which are part of the bodys immune system. Symptoms depend on what area of the body is affected by the cancer and how fast the cancer is growing.Symptoms may include night sweats (soaking the bed sheets and pajamas even though the room temperature is not too hot),fever and chills that come and go, itching, swollen lymph nodes in the neck, underarms, groin, or other areas, weight loss, coughing or shortness of breath if the cancer affects the thymus gland or lymph nodes in the chest, putting pressure on the windpipe (trachea) or other airway, abdominal pain or swelling, leading to loss of appetite, constipation, nausea, and vomiting and headache, concentration problems, personality changes, or seizures if the cancer affects the brain. Treatment includes surgery, radiation therapy and chemotherapy.
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=1135786
Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Non-Hodgkin Lymphoma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Non-Hodgkin Lymphoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Non-Hodgkin Lymphoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 6, 2, 28, 137, 124, 5, 123, 18 and 3 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 15, 17, 16 and 4 molecules, respectively.
Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html
Table of Contents
Table of Contents 2
Introduction 11
Non-Hodgkin Lymphoma - Overview 12
Non-Hodgkin Lymphoma - Therapeutics Development 13
Non-Hodgkin Lymphoma - Therapeutics Assessment 85
Non-Hodgkin Lymphoma - Companies Involved in Therapeutics Development 111
Non-Hodgkin Lymphoma - Drug Profiles 233
Non-Hodgkin Lymphoma - Dormant Projects 1656
Non-Hodgkin Lymphoma - Discontinued Products 1676
Non-Hodgkin Lymphoma - Product Development Milestones 1684
Appendix 1692
List of Tables
Number of Products under Development for Non-Hodgkin Lymphoma, H1 2017 60
Number of Products under Development by Companies, H1 2017 62
Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017 63
Number of Products under Development by Companies, H1 2017 (Contd..2), H1 2017 64
Number of Products under Development by Companies, H1 2017 (Contd..3), H1 2017 65
Number of Products under Development by Companies, H1 2017 (Contd..4), H1 2017 66
Number of Products under Development by Companies, H1 2017 (Contd..5), H1 2017 67
Number of Products under Development by Companies, H1 2017 (Contd..6), H1 2017 68
Number of Products under Development by Companies, H1 2017 (Contd..7), H1 2017 69
Number of Products under Development by Companies, H1 2017 (Contd..8), H1 2017 70
About ResearchMoz
ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Contact Us:
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Hodgkin Lymphoma Market - Pipeline Review, H1 2017 provides Comprehensive Information on the Therapeutics under Development here
News-ID: 570277 • Views: …
More Releases from Non-Hodgkin Lymphoma
Heat Map and Analysis on Non-Hodgkin Lymphoma | Industry Analysis & Outlook
Researchmoz added latest report "Non-Hodgkin Lymphoma - Heat Map and Analysis". The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
Non-Hodgkin lymphomas (NHL) are a heterogeneous group of malignancies that originate from lymphoid tissue, with varied clinical and biological features. There were an estimated 385,741 new cases of NHL and 199,630 deaths from NHL worldwide in 2012. NHLs are…
Latest Research Report on Non-Hodgkin Lymphoma - Heat Map and Analysis | Researc …
Researchmoz added Most up-to-date research on "Non-Hodgkin Lymphoma - Heat Map and Analysis" to its huge collection of research reports.
Non-Hodgkin lymphomas (NHL) are a heterogeneous group of malignancies that originate from lymphoid tissue, with varied clinical and biological features. There were an estimated 385,741 new cases of NHL and 199,630 deaths from NHL worldwide in 2012. NHLs are classified as either indolent (slow-growing) or aggressive (fast-growing). Almost 85% of NHLs…
Non-Hodgkin Lymphoma Innovative Licensing Industry Opportunities Key Trends, Siz …
Researchmoz added Most up-to-date research on "Frontier Pharma: Innovative Licensing Opportunities in Non-Hodgkin Lymphoma" to its huge collection of research reports.
Non-Hodgkin Lymphoma (NHL) can be seen as a collection of up to 60 smaller subtypes of malignant lymphoid disease, defined by distinct morphological, cytogenetic and immunophenotypic characteristics that can be broadly classified as either indolent or aggressive disease. The slow growing nature of the former means that first-line treatment for…
Non-Hodgkin Lymphoma - Heat Map and Analysis Industry Key Trends, Size, Growth, …
Researchmoz added Most up-to-date research on "Non-Hodgkin Lymphoma - Heat Map and Analysis" to its huge collection of research reports.
Non-Hodgkin lymphomas (NHL) are a heterogeneous group of malignancies that originate from lymphoid tissue, with varied clinical and biological features. There were an estimated 385,741 new cases of NHL and 199,630 deaths from NHL worldwide in 2012. NHLs are classified as either indolent (slow-growing) or aggressive (fast-growing). Almost 85% of NHLs…
More Releases for Companies
US Residential Construction Companies Database (49,000 companies)
We are delighted to announce the addition of the US Residential Construction Companies Database to our catalogue, containing nearly 50,000 residential construction companies in the United States.
US Residential Construction Companies Database (49,000 companies) is an Excel spreadsheet containing a list of the largest Residential Construction Companies in the United States. The combined list includes the largest residential construction companies within each of 49 states. This database contains the leading companies…
Customer Satisfaction Survey Companies | Customer Satisfaction Survey Report | C …
A survey conducted to obtain the feedback from the consumers is very much essential. It is very much essential to know the demands of consumers especially for the small organizations, so that they can produce the products to fulfill the requirements of their consumers and thereby build consumer loyalty and boost the sales. A survey to control the requirements of consumers is of the paramount importance for the growth and…
Saudi Arabia Pharmaceutical Market | pharmaceutical companies in saudi arabia, p …
In order to study the various trends and patterns prevailing in the concerned market, Market Research Reports Search Engine (MRRSE) has included a new report titled “Saudi Arabia Pharmaceutical Market” to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to transform the global market in the near future.
The report examines Saudi Arabia pharmaceutical market for the period 2016–2026. The primary…
Personal Artificial Intelligence And Robotics Market Share, Growth by Top Compan …
The research examines personalized robots, bot software, and systems. The report assesses the impact of AI and evaluates the market for AI enhanced robots and robotic systems for the consumer market. The global Personal Artificial Intelligence and Robotics market is segmented based on deployment, technology, application, industry, and region. Based on deployment, the market is bifurcated into cloud and On-Premise. The On-Premise segment is anticipated to dominate the global market…
Global Infertility Treatment Market Top Companies - Cooper Companies Inc., Vitro …
Global Infertility Treatment Market By Procedure (ART, Artificial Insemination, IVF, Surrogacy, Fertility Surgery), Product (Instruments, Media, Accessories), Patient Type (Male, Female), End User (Fertility Clinics, Hospitals, Cryobanks), Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024
The global infertility treatment market accounted to USD 1.21 billion in 2016 growing at a CAGR of 10.8% during the forecast period of 2017 to…
A trend of diagnostic companies collaborating with pharmaceutical companies : Kn …
In vitro diagnostics provide valuable information regarding the physiological and/or pathological state of body and therefore are very essential to take well-informed medical decisions. This report estimates the market for the in vitro diagnostics terms of revenue (USD million) for the period 2012 – 2018, keeping 2011 as the base year. The in vitro diagnostics market is segmented into two major types namely market by geography and market by products.…
